Literature DB >> 22525563

The antioxidant properties of high-density lipoproteins in atherosclerosis.

B Mackness1, M Mackness.   

Abstract

High-density lipoprotein (HDL) is protective against atherosclerosis development. Other than its central role in reverse cholesterol transport, HDL exhibits several other mechanisms by which it is protective. These include antioxidative, anti-inflammatory and antiapoptopic activities and the normalisation of vascular function. In light of the current view that oxidative modification of low-density lipoprotein (LDL) is essential for the initiation and progression of atherosclerosis, the antioxidative properties of HDL may be an important protective mechanism. HDL can retard the oxidation of LDL and limit its atherogenicity. Several proteins are present on HDL and the evidence that some of them metabolise lipid peroxidation products of phospholipids, cholesteryl esters and triglycerides associated with LDL and vascular cell membranes are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525563

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  14 in total

1.  Paraoxonase 1 - an Update of the Antioxidant Properties of High- Density Lipoproteins.

Authors:  Bogdan Nicolae Manolescu; Carmina Busu; Daniela Badita; Ruxandra Stanculescu; Mihai Berteanu
Journal:  Maedica (Buchar)       Date:  2015-06

2.  Multi-dimensional co-separation analysis reveals protein-protein interactions defining plasma lipoprotein subspecies.

Authors:  Scott M Gordon; Jingyuan Deng; Alex B Tomann; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  Mol Cell Proteomics       Date:  2013-07-23       Impact factor: 5.911

Review 3.  Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Authors:  Mike Mackness; Bharti Mackness
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

4.  The determinants of collateral circulation status in patients with chronic cerebral arterial circle occlusion: A STROBE Study.

Authors:  Chenghui Pi; Jun Wang; Dengfa Zhao; Shengyuan Yu
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

5.  High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.

Authors:  Scott M Gordon; Jonathan H Chung; Martin P Playford; Amit K Dey; Denis Sviridov; Fayaz Seifuddin; Yun-Ching Chen; Mehdi Pirooznia; Marcus Y Chen; Nehal N Mehta; Alan T Remaley
Journal:  Atherosclerosis       Date:  2018-09-25       Impact factor: 5.162

6.  Anticipatory role of high density lipoprotein and endothelial dysfunction: an overview.

Authors:  Esin Eren; Necat Yılmaz; Ozgur Aydin; Hamit Y Ellidağ
Journal:  Open Biochem J       Date:  2014-12-31

7.  Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients.

Authors:  Guido Gembillo; Rossella Siligato; Valeria Cernaro; Ersilia Satta; Giovanni Conti; Antonino Salvo; Adolfo Romeo; Vincenzo Calabrese; Giovanna Sposito; Guido Ferlazzo; Domenico Santoro
Journal:  Int Urol Nephrol       Date:  2021-06-09       Impact factor: 2.370

Review 8.  Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL.

Authors:  Peiqiu Cao; Haitao Pan; Tiancun Xiao; Ting Zhou; Jiao Guo; Zhengquan Su
Journal:  Int J Mol Sci       Date:  2015-07-28       Impact factor: 5.923

9.  Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis.

Authors:  Aytac Atamer; Ayse O Kurdas-Ovunc; Atakan Yesil; Yildiz Atamer
Journal:  Saudi J Gastroenterol       Date:  2014 Jan-Feb       Impact factor: 2.485

Review 10.  Functionally defective high-density lipoprotein and paraoxonase: a couple for endothelial dysfunction in atherosclerosis.

Authors:  Esin Eren; Necat Yilmaz; Ozgur Aydin
Journal:  Cholesterol       Date:  2013-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.